KFSH&RC Leads Global Healthcare Revolution with AI and Robotics
June 27, 2024 09:00 ET
|
King Faisal Specialist Hospital & Research Centre
King Faisal Specialist Hospital & Research Centre (KFSH&RC) Leads the Global Healthcare Revolution with AI and Robotics
Qure.ai announces strategic investment by Merck Global Health Innovation Fund to boost innovation of healthcare AI
June 25, 2024 09:00 ET
|
Qure.ai Technologies Limited
Qure.ai announces strategic investment by Merck Global Health Innovation Fund to boost innovation of healthcare AI.
Allecra Therapeutics and Acino Sign Exclusive Licensing and Supply Agreement for Allecra’s Novel Antibiotic EXBLIFEP® in Gulf Cooperation Council countries and South Africa
June 24, 2024 03:00 ET
|
Acino International AG
Saint-Louis, France and Weil am Rhein, Germany and Zurich, Switzerland, June 24, 2024 (GLOBE NEWSWIRE) -- Allecra Therapeutics (“Allecra”) and Acino today announced the signing of an exclusive...
Spherix Global Insights Appoints Leigh Anne Siino as Chief Revenue Officer
June 17, 2024 15:43 ET
|
Spherix Global Insights
EXTON, PA, June 17, 2024 (GLOBE NEWSWIRE) -- Spherix Global Insights, a leading independent market intelligence and advisory firm that delivers commercial value to the global life sciences industry,...
Adalvo Secures First EU Generic Approval for Liraglutide Pre-Filled Pen
June 13, 2024 06:38 ET
|
ADALVO LIMITED
Adalvo announces the successful DCP approval for Liraglutide pre-filled pen, marking it as the first generic approval in the EU.
[Latest] Global Protein Purification and Isolation Market Size/Share Worth USD 22,003.8 Million by 2033 at a 9.2% CAGR: Custom Market Insights (Analysis, Outlook, Leaders, Report, Trends, Forecast, Segmentation, Growth, Growth Rate, Value)
June 10, 2024 09:00 ET
|
Custom Market Insights
Austin, TX, USA, June 10, 2024 (GLOBE NEWSWIRE) -- Custom Market Insights has published a new research report titled “Protein Purification and Isolation Market Size, Trends and Insights By Product...
Sermonix Pharmaceuticals Announces Chinese Approval of Investigational New Drug Application for Lasofoxifene
June 06, 2024 09:00 ET
|
Sermonix Pharmaceuticals Inc.
IND approval in China allows Shanghai Henlius Biotech, Sermonix’s Chinese development partner for oral lasofoxifene, to enroll ELAINE-3 trial patients in ChinaUnder strategic collaboration agreement...
23andMe Therapeutics Announces Positive Preliminary Phase 2 Safety and Efficacy Results for 23ME-00610, targeting CD200R1, at the 2024 ASCO Annual Meeting
June 03, 2024 08:00 ET
|
23andMe, Inc.
– 23ME-00610 monotherapy demonstrates preliminary evidence of clinical benefit, including one confirmed partial response – 23ME-00610 monotherapy continues to demonstrate acceptable safety and...
Biognosys launches groundbreaking P2 Plasma Enrichment technology for unbiased, deep plasma proteomics at ASMS 2024
May 30, 2024 09:15 ET
|
Biognosys AG
Biognosys launches single-well, single particle-type P2 Plasma Enrichment technology with market-leading performance for unbiased, deep plasma proteomics
Rhino Health and Medinexo Partner to Expand Data Diversity in Therapeutic Development
May 22, 2024 15:35 ET
|
Rhino Health
Rhino Health and Medinexo are partnering to provide federated access to a global network of hospitals to accelerate biopharma research.